INSURASALES

Sapiens to Acquire Candela to Boost Life Insurance Automation in APAC

Sapiens acquires Candela for $22M to enhance life insurance automation and expand in APAC. Integration aims to streamline insurance platforms and support digital transformations in the sector.

AI Advancements Revolutionizing Life Insurance Underwriting and Cancer Diagnosis

Explore how AI is transforming life insurance underwriting and cancer diagnosis by enhancing risk assessment and enabling personalized treatment through advanced data analytics.

New Jersey Adopt Best-Interest Annuity Standards as 50th State

New Jersey completes nationwide adoption of NAIC best-interest annuity standards, aligning state and federal regulations on insurance producer obligations and consumer protections.

HaysMed CEO Represents Rural Healthcare at HHS Policy Roundtable

HaysMed CEO Edward Herrman joined a key HHS healthcare policy roundtable discussing rural healthcare challenges, Medicare Advantage concerns, regulatory burdens, and AI opportunities. Insights to inform federal support and reform.

Impact of Proposed Medicaid and Medicare Cuts on Massachusetts Care Providers

U.S. Rep. Richard Neal discusses the potential impact of federal budget cuts to Medicaid and Medicare on Massachusetts long-term care providers and residents.

Medicare Drug Coverage and Costs for Jardiance in Heart Failure and Diabetes Care

Explore how Medicare Part D and C plans cover Jardiance for heart failure and type 2 diabetes, including costs, formularies, and pricing reforms under the Inflation Reduction Act.

Medicare Drug Cost Sharing Shifts Drive Higher Patient Expenses

Medicare beneficiaries face higher costs as Part D plans shift from fixed co-pays to coinsurance for expensive Tier 3 drugs, raising out-of-pocket expenses significantly.

Caremark Faces Whistleblower Lawsuit Over Medicare Part D Overbilling Claims

Caremark is accused of overbilling Medicare Part D by $240-$330 million in a whistleblower lawsuit, raising significant regulatory and compliance concerns for PBMs.

Medicare Genetic Testing Fraud Case Settled for $6M Over False Claims

Genexe and Immerge settle $6M case resolving false Medicare claims for unnecessary genetic tests involving kickbacks. Settlement addresses healthcare fraud and whistleblower suits under the False Claims Act.

Trump Administration's Extensive Federal Workforce Reductions and Agency Restructuring

Detailed analysis of the Trump administration's extensive federal workforce reductions affecting key agencies like EPA, HHS, IRS, and others, with implications for federal compliance and operations.